IODINATED CONTRAST MEDIA DECREASE RENOMEDULLARY BLOOD FLOW A possible cause of contrast media-induced nephropathy

被引:11
|
作者
Liss, Per [1 ]
Hansell, Peter [2 ]
Carlsson, Per-Ola [2 ]
Fasching, Angelica [2 ]
Palm, Fredrik [2 ]
机构
[1] Uppsala Univ, Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden
[2] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, SE-75123 Uppsala, Sweden
来源
关键词
RECEPTOR ANTAGONIST; DIABETES-MELLITUS; RENAL DYSFUNCTION; HYPOXIC INJURY; RADIOCONTRAST; ADENOSINE; ENDOTHELIN; CATHETERIZATION; NEPHROTOXICITY; RESPONSES;
D O I
10.1007/978-0-387-85998-9_33
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The renal medulla has been implicated as a key target for contrast media-induced nephropathy (CIN). Although the effects of contrast media (CM) on whole kidney blood flow are well characterized, the effect of CM oil renal medullary blood now has been controversial. It has been reported that an extremely high dose of a high osmolar CM (iothalamate; 2900 mg l/kg bw) injected rapidly increased the renal outer medullary blood flow (OMBF), However, more clinical relevant doses consistently result in a Sustained decrease in medullary blood flow. Furthermore, simultaneous measurements using both laser-Doppler flowmetry and hydrogen washout yield similar results of a decrease in OMBF after CM administration. CM induced a transient 28% decrease in the laser-Doppler signal from the Outer medulla, while the hydrogen washout rate in the same region was reduced by approximately 50%. Furthermore, CM administration consistently results in decreased medullary oxygen tension (P-O2). The renal medulla works already during normal physiological conditions at the verge or hypoxia, and the majority of the Studies published so far are in agreement with the hypothesis that CIN may have its origin in a further reduction in blood flow and/or oxygen availability of this region of the kidney.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [2] CONTRAST MEDIA-INDUCED NEPHROPATHY
    FLEISCHMANN, E
    LUFT, FC
    MANN, J
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (05) : 177 - 186
  • [3] IODINATED CONTRAST MEDIA-INDUCED NEPHROPATHY - PATHOPHYSIOLOGY, CLINICAL ASPECTS AND PREVENTION
    IDEE, JM
    BEAUFILS, H
    BONNEMAIN, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (03) : 193 - 206
  • [4] Prophylaxis of iodinated contrast media-induced nephropathy -: A pharmacological point of view
    Idée, JM
    Lancelot, E
    Pines, E
    Corot, C
    INVESTIGATIVE RADIOLOGY, 2004, 39 (03) : 155 - 170
  • [5] Prophylaxis of Contrast Media-Induced Nephropathy
    Manker, W.
    JOURNAL FUR KARDIOLOGIE, 2006, 13 (11-12): : 344 - 350
  • [6] Iodinated contrast media-induced fixed drug eruption
    Shim, Jisu
    Chung, Soojie
    Kim, Gun-Woo
    Sohn, Kyoung-Hee
    Kim, Ju-Young
    Kang, Hye-Ryun
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2015, 3 (05): : 375 - 379
  • [7] Current concepts in contrast media-induced nephropathy
    Tublin, ME
    Murphy, ME
    Tessler, FN
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (04) : 933 - 939
  • [8] A Review: Radiographic Iodinated Contrast Media-Induced Thyroid Dysfunction
    Lee, Sun Y.
    Rhee, Connie M.
    Leung, Angela M.
    Braverman, Lewis E.
    Brent, Gregory A.
    Pearce, Elizabeth N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : 376 - 383
  • [9] Dietary hypercholesterolemia aggravates contrast media-induced nephropathy
    杨定位
    贾汝汉
    杨定平
    丁国华
    黄从新
    Chinese Medical Journal, 2004, (04)
  • [10] How to protect from contrast media-induced nephropathy?
    Scheller, B.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (03) : 125 - 129